Equillium (EQ) Exchange Rate Effect (2019 - 2026)
Equillium (EQ) reported Exchange Rate Effect of $3000.0 for Q1 2026, up 400.0% year-over-year from $600.0 in Q1 2025, and down 92.31% on a QoQ basis from $39000.0 in Q4 2025.
Equillium (EQ) has 8 years of Exchange Rate Effect data on file, last reported at $3000.0 in Q1 2026.
- Quarterly Exchange Rate Effect rose 400.0% year-over-year to $3000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $51000.0 (up 176.12% YoY) and the FY2025 annual result came in at $47000.0, up 156.63% from the prior year.
- Exchange Rate Effect retreated to $3000.0 in Q1 2026 per EQ's latest filing, from $39000.0 in the prior quarter.
- Across five years, Exchange Rate Effect topped out at $48000.0 in Q3 2024 and bottomed at -$133000.0 in Q4 2024.
- The 5-year median for Exchange Rate Effect is -$3000.0 (2022), against an average of -$8588.2.
- The widest annual swing landed in 2024, when Exchange Rate Effect tumbled 1800.0%; it then soared 400.0% in 2026.
- Tracing EQ's Exchange Rate Effect over 5 years: stood at $31000.0 in 2022, then slumped by 148.39% to -$15000.0 in 2023, then plunged by 786.67% to -$133000.0 in 2024, then surged by 129.32% to $39000.0 in 2025, then sank by 92.31% to $3000.0 in 2026.
- Per Business Quant, the three latest EQ Exchange Rate Effect figures stand at $3000.0 (Q1 2026), $39000.0 (Q4 2025), and -$13000.0 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | 3.60 Mn |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | -2.70 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | -40.30 Mn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | -900,000.00 |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | -7.06 Mn |
| 10 | Equillium | 279.21 Mn | 218.82 Mn | - | 3,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3,000.00 |
| Mar 31, 2026 | 3,000.00 |
| Dec 31, 2025 | 39,000.00 |
| Dec 31, 2025 | 39,000.00 |
| Sep 30, 2025 | -13,000.00 |
| Sep 30, 2025 | -13,000.00 |
| Jun 30, 2025 | 22,000.00 |
| Jun 30, 2025 | 22,000.00 |
| Mar 31, 2025 | -1,000.00 |
| Mar 31, 2025 | -1,000.00 |
| Dec 31, 2024 | -133,000.00 |
| Dec 31, 2024 | -133,000.00 |
| Sep 30, 2024 | 48,000.00 |
| Sep 30, 2024 | 48,000.00 |
| Jun 30, 2024 | 19,000.00 |
| Jun 30, 2024 | 19,000.00 |
| Mar 31, 2024 | -17,000.00 |
| Mar 31, 2024 | -17,000.00 |
| Dec 31, 2023 | -15,000.00 |
| Dec 31, 2023 | -15,000.00 |
| Sep 30, 2023 | -58,000.00 |
| Sep 30, 2023 | -58,000.00 |
| Jun 30, 2023 | -46,000.00 |
| Jun 30, 2023 | -46,000.00 |
| Mar 31, 2023 | 1,000.00 |
| Mar 31, 2023 | 1,000.00 |
| Dec 31, 2022 | 31,000.00 |
| Dec 31, 2022 | 31,000.00 |
| Sep 30, 2022 | -14,000.00 |
| Sep 30, 2022 | -14,000.00 |
| Jun 30, 2022 | -9,000.00 |
| Jun 30, 2022 | -9,000.00 |
| Mar 31, 2022 | -3,000.00 |
| Mar 31, 2022 | -3,000.00 |
| Dec 31, 2021 | 8,000.00 |
| Dec 31, 2021 | 8,000.00 |
| Sep 30, 2021 | -2,000.00 |
| Sep 30, 2021 | -2,000.00 |
| Jun 30, 2021 | -7,000.00 |
| Jun 30, 2021 | -7,000.00 |
| Mar 31, 2021 | -1,000.00 |
| Mar 31, 2021 | -1,000.00 |
| Dec 31, 2020 | 11,000.00 |
| Dec 31, 2020 | 11,000.00 |
| Sep 30, 2020 | 40,000.00 |
| Sep 30, 2020 | 40,000.00 |
| Jun 30, 2020 | -2,000.00 |
| Jun 30, 2020 | -2,000.00 |
| Mar 31, 2020 | -15,000.00 |
| Mar 31, 2020 | -15,000.00 |
| Dec 31, 2019 | 30,000.00 |
| Dec 31, 2019 | 30,000.00 |
| Sep 30, 2019 | -24,000.00 |
| Sep 30, 2019 | -24,000.00 |